Edition:
United Kingdom

People: Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

25.64USD
16 Aug 2019
Change (% chg)

$0.28 (+1.10%)
Prev Close
$25.36
Open
$25.59
Day's High
$26.05
Day's Low
$25.46
Volume
200,262
Avg. Vol
233,427
52-wk High
$33.79
52-wk Low
$17.90

Myer, Vickesh 

Dr. Vickesh Myer is Chief Technology Officer of the Company. Prior to joining our company, Dr. Myer served as Executive Director, Cambridge Site Head, Developmental and Molecular Pathways Department at Novartis Institutes for Biomedical Research, a global pharmaceutical research organization of Novartis International AG, from April 2004 until April 2015. Dr. Myer received his B.S. in biology from Cornell University and his Ph.D. in molecular biophysics and biochemistry from Yale University.

Basic Compensation

Total Annual Compensation, USD 486,926
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,968,810
Fiscal Year Total, USD 2,455,740

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Mullen

612,362

Cynthia Collins

479,814

Eric Ek

--

Vickesh Myer

2,455,740

Charles Albright

2,387,900

Katrine Bosley

7,989,380
As Of  31 Dec 2018